Fig. 1From: Impact of bilateral biopsy-detected prostate cancer on an active surveillance populationReclassification to bilateral-biopsy detected cancer on patient follow-up. The flow chart demonstrates 41% of patients had bilateral cancer on repeated biopsies of which 66% had reclassification of their disease versus 19.5% of patients with unilateral cancerBack to article page